Inicure
TechnologyPipelineWhy InicureAboutNewsPartner with us
Back to news

23 September 2025

Biotech Hanse Stockholm September 2025

CEO Peter Olofsson-Sahl presented Inicure at the #BiotechHanse event as an innovative Swedish life science innovation for Sweden–Germany collaboration and partnership opportunities.

PreviousIMPACT ODINNextLead optimisation support from Scilife DDD

Partnering

Let's advance the next generation of anti-infectives together.

We are actively seeking collaborations and partnerships to advance our development, with the aim of delivering next-generation products in the battle against infections.

Start a partnering conversation

Contact

Peter Olofsson-Sahl

CEO

peter.olofsson-sahl@inicure.com

Company

Inicure AB
Gothenburg, Sweden
Founded 2024

© 2026 Inicure AB. All rights reserved.

All data described is from preclinical studies.